Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cullinan Therapeutics, Inc. CGEM

Set alert

Price alert · CGEM

All alert types
14.93 USD -0.10 -0.67%

At close · Nov 2

14.93 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
14.92 × 2
Ask
14.93 × 2
14.63 Day range 15.35
6.73 52-week range 23.19
YTD
+44.25%
1 year
+72.40%
Open
15.13
Prev close
15.03
Mkt cap
917.57M
Vol
730.77K
Avg vol
898.29K
EPS
-3.11
P/E
0.00
Div yield
0.00%
More statistics
Low
14.63
High
15.35
Forward P/E
-6.30
Beta
-0.04
Short ratio
6.17
Inst. own
112.54%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
18.28
200-d avg
15.74
1y target
34.60

1D chart

Chart tools
Interval
1m5m15m30m

Signals (47)
NameTimeAgo
MACD: Sell Signal3:56 PM14 hours ago
SMA: Bearish3:54 PM14 hours ago
MACD: Buy Signal3:47 PM14 hours ago
SMA: Bearish3:40 PM14 hours ago
MACD: Sell Signal3:25 PM14 hours ago
RSI: Overbought3:05 PM15 hours ago
SMA: Bullish2:53 PM15 hours ago
SMA: Bullish2:53 PM15 hours ago
MACD: Buy Signal2:43 PM15 hours ago
SMA: Bearish2:20 PM16 hours ago
SMA: Bearish2:20 PM16 hours ago
MACD: Sell Signal2:20 PM16 hours ago
SMA: Bullish2:18 PM16 hours ago
SMA: Bullish2:18 PM16 hours ago
SMA: Bearish2:17 PM16 hours ago
SMA: Bearish2:17 PM16 hours ago
SMA: Bullish2:08 PM16 hours ago
SMA: Bearish2:04 PM16 hours ago
SMA: Bullish2:03 PM16 hours ago
SMA: Bearish1:57 PM16 hours ago

Newest 20 of 47.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 34.60 +131.7% upside
Target (low)
27.00
Target (mean)
34.60
Target (high)
42.00
Ratings (0m) 12 12 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy11
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 12
  • 1 month ago 12
  • 2 months ago 12
  • 3 months ago 12

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CGEM analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.83991-1.04 – -0.71-0.77-9.1%00.0%9
Next quarter-0.69919-1.16 – 0.71373-0.77+9.2%11.56M0.0%9
Current year-3.13-3.79 – -1.85-3.36+7.0%13.88M0.0%9
Next year-2.47-3.93 – -1.25-3.13+20.9%55.51M+300.0%9

Upgrades and downgrades

The latest rating changes

CGEM analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026BTIGMaintainedBuyBuy
Oct 19, 2026BTIGReiteratedBuyBuy
Oct 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 25, 2026HC Wainwright & Co.MaintainedBuyBuy
Sep 25, 2026BTIGReiteratedBuyBuy
Sep 14, 2026BTIGMaintainedBuyBuy
Aug 17, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 13, 2026WedbushMaintainedOutperformOutperform
Jul 29, 2026BTIGMaintainedBuyBuy
Jun 11, 2026WedbushReiteratedOutperformOutperform
Jun 8, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 19, 2026BTIGReiteratedBuyBuy
May 8, 2026WedbushMaintainedOutperformOutperform
May 4, 2026BTIGReiteratedBuyBuy
Apr 28, 2026HC Wainwright & Co.MaintainedBuyBuy
Apr 28, 2026BTIGReiteratedBuyBuy
Mar 11, 2026WedbushMaintainedOutperformOutperform
Feb 17, 2026CitigroupInitiated—Buy
Feb 2, 2026GuggenheimInitiated—Buy
Jan 8, 2026HC Wainwright & Co.MaintainedBuyBuy
Dec 9, 2025WedbushMaintainedOutperformOutperform
Nov 20, 2025HC Wainwright & Co.MaintainedBuyBuy
Sep 12, 2025HC Wainwright & Co.ReiteratedBuyBuy
Sep 10, 2025BTIGReiteratedBuyBuy
Aug 18, 2025Morgan StanleyMaintainedOverweightOverweight
May 12, 2025UBSMaintainedBuyBuy
Apr 16, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 28, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 28, 2025StifelMaintainedBuyBuy
Oct 24, 2024UBSInitiated—Buy